Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00780442 · ClinicalTrials.gov registry record · Phase 2
D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals
A Phase 2 study of Cocaine Use Disorders, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT00780442 is a Phase 2 study of Cocaine Use Disorders that has completed, run by Medical University of South Carolina. The registered enrollment target is 27 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00780442, a Phase 2 study of Cocaine Use Disorders, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
In summary, this pilot study will explore the use of an innovative pharmacologic approach to the treatment of substance dependence through the facilitation of extinction of response to cocaine-conditioned cues in cocaine-dependent individuals. If DCS proves successful in this preliminary study, a controlled treatment trial will be planned. This novel approach could have implications for the treatment of multiple substance use disorders including methamphetamine, marijuana and opiate dependence.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG D-cycloserine
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00780442
The ClinicalTrials.gov registry entry for NCT00780442 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cocaine Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00780442 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT00780442 about?
NCT00780442 is a clinical study titled "D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals". In summary, this pilot study will explore the use of an innovative pharmacologic approach to the treatment of substance dependence through the facilitation of extinction of response to cocaine-conditioned cues in cocaine-dependent individuals. If DCS proves successful in this preliminary study, a co...
What is the current status of trial NCT00780442?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2006-09. Estimated completion is 2008-07.
What conditions does trial NCT00780442 study?
This clinical trial studies the following conditions: Cocaine Use Disorders.
What interventions are being tested in trial NCT00780442?
The interventions under investigation include: Placebo (DRUG), D-cycloserine (DRUG).
Who is sponsoring clinical trial NCT00780442?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00780442 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.